Search

Your search keyword '"Bosch, F"' showing total 4,871 results

Search Constraints

Start Over You searched for: Author "Bosch, F" Remove constraint Author: "Bosch, F"
4,871 results on '"Bosch, F"'

Search Results

51. Scaling Relations of Spiral Galaxies

52. New Mass and Lifetime Measurements of $^{152}$Sm Projectile Fragments with Time-Resolved Schottky Mass Spectrometry

53. Electron gas polarization effect induced by heavy H-like ions of moderate velocities channeled in a silicon crystal

54. Isospin Dependence in the Odd-Even Staggering of Nuclear Binding Energies

56. The clustering of galaxies in the sdss-iii baryon oscillation spectroscopic survey: The low-redshift sample

57. The Central Mass Distribution in Dwarf and Low Surface Brightness Galaxies

58. Posttransplant monomorphic Burkitt’s lymphoma: clinical characteristics and outcome of a multicenter series

59. Dusty Nuclear Disks and Filaments in Early Type Galaxies

60. Radiative recombination of bare Bi83+: Experiment versus theory

61. Mergers in λCDM: Uncertainties in theoretical predictions and interpretations of the merger rate

64. COMBINING CD19‐4‐1BBL (RO7227166) WITH GLOFITAMAB IS SAFE AND SHOWS EARLY EFFICACY IN PATIENTS SUFFERING FROM RELAPSED OR REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA

66. GLOFITAMAB PLUS POLATUZUMAB VEDOTIN DEMONSTRATES DURABLE RESPONSES AND A MANAGEABLE SAFETY PROFILE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

68. Evidence for a 3 x 10^8 solar mass black hole in NGC 7052 from HST observations of the nuclear gas disk

71. Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study)

75. POS1107 BIMEKIZUMAB ACHIEVED SUSTAINED IMPROVEMENTS IN EFFICACY OUTCOMES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, REGARDLESS OF PRIOR TNF INHIBITOR TREATMENT: WEEK 52 POOLED RESULTS FROM TWO PHASE 3 STUDIES

77. OP0062 EULAR POINTS TO CONSIDER FOR THE DEFINITION OF CLINICAL AND IMAGING FEATURES SUSPICIOUS FOR PROGRESSION TO PSORIATIC ARTHRITIS

78. POS0683 AN EXPLORATORY ANALYSIS OF THE POTENTIAL DISCONNECT BETWEEN OBJECTIVE INFLAMMATORY RESPONSE AND CLINICAL RESPONSE FOLLOWING CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS

81. POS0250 PLACEBO-CONTROLLED EFFICACY AND SAFETY OF UPADACITINIB THROUGH ONE YEAR IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS

82. OP0055 ASAS CONSENSUS DEFINITION OF EARLY AXIAL SPONDYLOARTHRITIS

84. POS0672 RHEUMATOLOGISTS OVERCALL SACROILIITIS ON X-RAY AND MRI IN AXIAL SPONDYLOARTHRITIS PATIENTS: DATA FROM THE BELGIAN INFLAMMATORY ARTHRITIS AND SPONDYLITIS COHORT (BE-GIANT)

85. Data from A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

86. Supplementary Tables 1-2 from A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

87. Supplementary Tables 1-2 from Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease

88. Supplementary Material from Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease

91. Biologische beheersing van plantenziekten met behulp van schimmels en bacteriën

97. Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study)

99. ESICM LIVES 2016: part two: Milan, Italy. 1–5 October 2016

Catalog

Books, media, physical & digital resources